source
- Roche signs up to $2 billion partnership with Atavistik to develop cardiometabolic drugsRoche announced a partnership with Atavistik Bio, a biotech focused on hematology, to pursue new small-molecule treatments for cardiovascular, renal and metabolic conditions. The agreement provide…
- Eli Lilly earmarks up to $3.25 billion for partnership with InnoCare PharmaEli Lilly announced an upfront payment of $100 million to Beijing‑based InnoCare Pharma to start work on drug candidates for five targets that have critical unmet medical needs. The agreement also…